Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [820]

Biomarker guidance allows patients 55 or older with low-grade luminal A-type...

Dr Timothy J. Whelan - McMaster University, Ontario, Canada

Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy ( Dr Timothy J. Whelan - McMaster University, Ontario, Canada )

Neoadjuvant ipilimumab and nivolumab immunotherapy could become new standard...

Dr Christian U. Blank - The Netherlands Cancer Institute, Amsterdam, Netherlands

Neoadjuvant ipilimumab and nivolumab immunotherapy could become new standard of care for resectable stage III melanoma ( Dr Christian U. Blank - The Netherlands Cancer Institute, Amsterdam, Netherlands )

COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity...

Dr Sumanta K. Pal - City of Hope Comprehensive Cancer Center, Duarte, USA

COSMIC-021: Cabozantinib plus atezolizumab gives encouraging clinical activity in inoperable locally advanced/metastatic urothelial carcinoma ( Dr Sumanta K. Pal - City of Hope Comprehensive Cancer Center, Duarte, USA )

Safety follow-up of the randomized, phase 3 study DESTINY-Breast03

Dr Erika Hamilton - Sarah Cannon Research Institute, Tennessee, USA

Safety follow-up of the randomized, phase 3 study DESTINY-Breast03 ( Dr Erika Hamilton - Sarah Cannon Research Institute, Tennessee, USA )

Phase III assessment of topotecan, cyclophosphamide and high-dose ifosfamide...

Dr Martin McCabe- University of Manchester, Manchester, England

$Phase III assessment of topotecan, cyclophosphamide and high-dose ifosfamide for refractory Ewing sarcoma patients ( Dr Martin McCabe- University of Manchester, Manchester, England )$

Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A...

Dr Prateek Jain - Tata Medical Center, Kolkata, India

Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A retrospective analysis of 104 patients ( Dr Prateek Jain - Tata Medical Center, Kolkata, India )

War in Ukraine: Impacts on the Ukrainian cancer care system

Dr Andriy Hrynkiv - Lviv Regional Cancer Centre of Ukraine, Lviv, Ukraine

War in Ukraine: Impacts on the Ukrainian cancer care system ( Dr Andriy Hrynkiv - Lviv Regional Cancer Centre of Ukraine, Lviv, Ukraine )

War in Ukraine: Current and future impacts on the Romanian cancer care system

Dr Nicoleta Antone - The Institute of Oncology, Cluj-Napoca, Romania

War in Ukraine: Current and future impacts on the Romanian cancer care system ( Dr Nicoleta Antone - The Institute of Oncology, Cluj-Napoca, Romania )

International Society of Paediatric Surgical Oncology (IPSO) surgical practice...

Dr Jaime Shalkow - National Institute of Paediatrics, Mexico City, Mexico

International Society of Paediatric Surgical Oncology (IPSO) surgical practice guidelines ( Dr Jaime Shalkow - National Institute of Paediatrics, Mexico City, Mexico )

KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant...

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

First randomized trial on adjuvant mitotane in adrenocortical carcinoma...

Prof Alfredo Berruti - University Of Brescia, Brescia, Italy

First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study. ( Prof Alfredo Berruti - University Of Brescia, Brescia, Italy )

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

More from ecancer